Donor Marrow Can Restore Fertility In Female Mice, MGH Researchers 
 Confirm
 
 Article Date: 04 Aug 2007 - 14:00 PDT
 
 A new study from Massachusetts General Hospital (MGH) researchers 
 confirms that female mice that receive bone marrow transplantation 
 after fertility-destroyin
 pregnancies throughout their normal reproductive life. The report in 
 the Journal of Clinical Oncology verifies that donor marrow can 
 restore fertility in female mice through an as-yet unidentified 
 mechanism. While donor-derived egg cells or oocytes were observed in 
 the ovaries of marrow recipients, all pups born were from the 
 recipients' own eggs. 
 
 "Consistent with our past work, cells derived from the donor bone 
 marrow are getting into the ovaries and developing into immature 
 oocytes," says Jonathan Tilly, PhD, director of the Vincent Center 
 for Reproductive Biology (http://www.vcrb.
 senior author. "Although these oocytes derived from marrow cells 
 don't appear competent, at least thus far, to make fertilizable eggs, 
 marrow does contribute something that allows a resumption of 
 fertility in female mice sterilized by chemotherapy.
 
 In a 2005 paper published in the journal Cell, Tilly's group found 
 that the ovaries of female mice that had received bone marrow or 
 blood cell transplants after fertility-destroyin
 chemotherapy appeared normal and contained immature oocytes 
 expressing a marker protein indicating they came from the donor 
 cells. This report followed a 2004 Nature paper, also from Tilly's 
 team, reporting that female mice continued producing eggs well into 
 adulthood, in contrast to the long-held belief that female mammals 
 are born with a finite supply of eggs that is depleted throughout 
 life. Both those papers have been extremely controversial, and the 
 current study was designed to follow up the 2005 paper and to address 
 criticisms raised by other researchers. 
 
 In the current study, adult female mice treated with infertility-
 inducing chemotherapy received bone marrow transplants from non-
 treated, healthy adult females either one week or two months after 
 chemotherapy. The mice were then housed with healthy adult males and 
 followed for 7 months, a time period in which a group of control 
 females achieved at least five successful pregnancies each. Both the 
 males and the donor females were black in coat color while the 
 recipient females were white-coated. As a result, the coat color of 
 any pups would indicate the source of egg cells used to make the 
 offspring, with tan coats signifying eggs from the recipients and 
 black coats indicating that the eggs had come from marrow donors. 
 
 Of the 10 females that received bone marrow transplants one week 
 after chemotherapy, all but one achieved several successful 
 pregnancies during the study period. One gave birth to four litters, 
 one gave birth to five litters, and seven gave birth to six litters 
 of pups. All pups were offspring of the recipients. In a comparison 
 group of 13 females that did not receive marrow after chemotherapy, 
 10 did become pregnant, but none delivered more than three litters. 
 
 Additional experiments indicated that mice receiving transplants one 
 week after chemotherapy had better fertility outcomes than did those 
 transplanted at eight weeks. Similarly, resuming mating sooner after 
 transplantation also improved fertility rates. When chemotherapy 
 doses were increased to levels expected to cause death in half the 
 mice, those that also received bone marrow transplants had improved 
 rates of both survival and long-term fertility. 
 
 The coat-color results of the mating trial indicated that the 
 transplanted marrow's contribution to restoring fertility did not 
 involve cells destined to becoming fertilizable eggs. To further 
 investigate this observation, the MGH-Vincent researchers gave 
 chemotherapy-
 express a green fluorescent protein (GFP) marker only on germline 
 cells, which are precursor cells involved in producing oocytes. Two 
 months after the transplant, the researchers observed GFP-marked 
 oocytes in immature follicles within recipient ovaries. However, 
 donor-derived oocytes made up less than 2 percent of the total number 
 of oocytes contained within follicles, and no mature follicles 
 contained GFP-marked cells. 
 
 Among the published reports raising objections to the previous work 
 of Tilly's group -- none of which actually attempted to duplicate 
 those experiments -- one theorized that GFP-marked cells observed in 
 recipient ovaries in the 2005 Cell paper might be donor immune cells 
 rather than oocytes. To address that conjecture, the MGH-Vincent team 
 isolated immune cells from normal mice, from the germline-only GFP 
 strain used in their experiments, and from a strain of mice 
 expressing GFP in all cells. Careful analysis confirmed that no 
 immune cells from the germline-only GFP strain contained the marker 
 protein, making it highly unlikely that GFP-labeled cells in the 
 ovaries of females receiving germline-only-
 anything other than oocytes. This was further confirmed by 
 experiments showing that isolated immune cells did not express the 
 oocyte-specific marker genes previously used by Tilly's group to 
 identify the marrow-derived oocytes. 
 
 Tilly and his colleague note that, since agents that protect 
 fertility most likely would need to be given before chemotherapy to 
 be effective, whatever the donor marrow contributes probably acts by 
 restoring rather than preserving fertility. "Right now, we really 
 don't know exactly what it is in marrow that restores recipient 
 oocyte production and rescues long-term fertility. However, we do 
 know without question that immature oocytes can be generated from 
 cells in adult bone marrow, but they are probably not critical to the 
 fertility rescue observed after the transplants.
 
 Since the 2005 Cell paper, Tilly points out, three studies have been 
 published by other groups showing that, similar to his team's work in 
 females, bone marrow cells from adult male mice or from men can be 
 coaxed to make immature sperm cells, both in lab dishes and after 
 transplantation into the testes. "Clearly, something is going on here 
 regarding the ability of stem cells in bone marrow to produce 
 immature egg and sperm cells, and we need to figure out what it is," 
 he says. Tilly is an associate professor of Obstetrics, Gynecology 
 and Reproductive Biology at Harvard Medical School. 
 
 ------------
 Article adapted by Medical News Today from original press release.
 ------------
 
 The first author of the study is Ho-Joon Lee, PhD, of the MGH-Vincent 
 Center for Reproductive Biology. Co-authors are Kaisa Selesniemi, 
 PhD, Yuichi Niikura, PhD, and Teruko Niikura, also of MGH-Vincent; 
 and Rachael Klein and David Dombkowski of the MGH Center for 
 Regenerative Medicine. The work was supported by grants from the 
 National Institutes of Health, Sea Breeze Foundation, JM Foundation 
 and Vincent Memorial Research Funds. 
 
 Massachusetts General Hospital (http://www.massgene
 established in 1811, is the original and largest teaching hospital of 
 Harvard Medical School. The MGH conducts the largest hospital-based 
 research program in the United States, with an annual research budget 
 of more than $500 million and major research centers in AIDS, 
 cardiovascular research, cancer, computational and integrative 
 biology, cutaneous biology, human genetics, medical imaging, 
 neurodegenerative disorders, regenerative medicine, systems biology, 
 transplantation biology and photomedicine. MGH and Brigham and 
 Women's Hospital are founding members of Partners HealthCare 
 HealthCare System, a Boston-based integrated health care delivery 
 system. 
 
 Source: Sue McGreevey 
 Massachusetts General Hospital 
 
 http://www.medicaln
 
 
«¤»¥«¤»§«¤»¥«¤»§«¤»¥«¤»«¤»¥«¤»§«¤»¥«¤»§«¤»¥«
¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯
StemCells subscribers may also be interested in these sites:
Children's Neurobiological Solutions
http://www.CNSfoundation.org/
Cord Blood Registry
http://www.CordBlood.com/at.cgi?a=150123
The CNS Healing Group
http://groups.yahoo.com/group/CNS_Healing
____________________________________________
«¤»¥«¤»§«¤»¥«¤»§«¤»¥«¤»«¤»¥«¤»§«¤»¥«¤»§«¤»¥«
¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯
 
 Change settings via the Web (Yahoo! ID required)
Change settings via email: Switch delivery to Daily Digest | Switch format to Traditional
Visit Your Group | Yahoo! Groups Terms of Use | Unsubscribe
__,_._,___
 
 
 
 
 

 






 
